Package Name: By Country - Canadian Stocks
Package Name: Bank Stocks
Package Name: Stocks Under 10 Dollars
Package Name: Currencies
Package Name: Gold Forecast
Our Winning Stock Forecast Ligand Pharmaceuticals Inc. (NASDAQ: LGND) is a mid-cap Biotech and Pharma company. The company has many programs of collaboration, in numbers, with 95 different Biotech and Pharmaceuticals companies including Baxter, Novartis, Pfizer and Bristol-Myers Squibb. Thanks to these collaborations, the company could arrive in 2020 to 24 new lines the product. However, shares have decreased about 14.9% since the last Earning report published in the end of September 2018. To confirm this, in mid-September price was $254.79 while the Average Volume for LGND shares was $344,030
Disclaimer:
I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, stock forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.